Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation?
Curative treatment of congenital toxoplasmosis is based on the association of pyrimethamine and sulfonamide. There is currently no pediatric galenic formulation. We report the case of a newborn child affected by asymptomatic congenital toxoplasmosis who received an overdose of pyrimethamine. The pat...
Gespeichert in:
| Veröffentlicht in: | Archives de pédiatrie : organe officiel de la Société française de pédiatrie 2011-10, Vol.18 (10), p.1084-1086 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | fre |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1086 |
|---|---|
| container_issue | 10 |
| container_start_page | 1084 |
| container_title | Archives de pédiatrie : organe officiel de la Société française de pédiatrie |
| container_volume | 18 |
| creator | Genuini, M Freihuber, C Girard, I de Montgolfier, I Kieffer, F Mitanchez, D |
| description | Curative treatment of congenital toxoplasmosis is based on the association of pyrimethamine and sulfonamide. There is currently no pediatric galenic formulation. We report the case of a newborn child affected by asymptomatic congenital toxoplasmosis who received an overdose of pyrimethamine. The patient received a dose of pyrimethamine 4 times, equal to 100 times the recommended dose, due to an error in the prescription. He had partial seizures 48 h after the last medicinal absorption. We noted a lack of appetite and vomiting, with a favorable progression in 5 days. Blood analysis showed isolated, spontaneously regressive moderate cholestasis. We propose a pharmacological clarification on the treatment of congenital toxoplasmosis. |
| doi_str_mv | 10.1016/j.arcped.2011.07.023 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_896204414</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>896204414</sourcerecordid><originalsourceid>FETCH-LOGICAL-p554-72064314c1414f3f0fd80e1da5bd1233881a7aa38a43b7f2529cf27a05072a5a3</originalsourceid><addsrcrecordid>eNo1kM1KxDAYRYMgzjj6BiLZuWr98tM240Zk8A8G3cxCcFG-tgmTsW1qkqLz9hYdV3dzOJd7CblgkDJg-fUuRV8Pukk5MJZCkQIXR2TOinyZ5Ll8m5HTEHYAoECJEzLjTKmM53JO3l-06zFiS20f3betMVrX0y8bt3TYe9vpuMXO9vqGehs-aDNqGh2NW02xCrqvNXWGTtUWo7c1Nc53Y_sruT0jxwbboM8PuSCbh_vN6ilZvz4-r-7WyZBlMik45FIwWTPJpBEGTKNAswazqmFcCKUYFohCoRRVYXjGl7XhBUIGBccMxYJc_WkH7z5HHWLZ2VDrtsVeuzGUaplzkJN8Ii8P5Fh1uimHaR_6ffl_h_gBZ49iSg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>896204414</pqid></control><display><type>article</type><title>Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Genuini, M ; Freihuber, C ; Girard, I ; de Montgolfier, I ; Kieffer, F ; Mitanchez, D</creator><creatorcontrib>Genuini, M ; Freihuber, C ; Girard, I ; de Montgolfier, I ; Kieffer, F ; Mitanchez, D</creatorcontrib><description>Curative treatment of congenital toxoplasmosis is based on the association of pyrimethamine and sulfonamide. There is currently no pediatric galenic formulation. We report the case of a newborn child affected by asymptomatic congenital toxoplasmosis who received an overdose of pyrimethamine. The patient received a dose of pyrimethamine 4 times, equal to 100 times the recommended dose, due to an error in the prescription. He had partial seizures 48 h after the last medicinal absorption. We noted a lack of appetite and vomiting, with a favorable progression in 5 days. Blood analysis showed isolated, spontaneously regressive moderate cholestasis. We propose a pharmacological clarification on the treatment of congenital toxoplasmosis.</description><identifier>EISSN: 1769-664X</identifier><identifier>DOI: 10.1016/j.arcped.2011.07.023</identifier><identifier>PMID: 21885264</identifier><language>fre</language><publisher>France</publisher><subject>Antiprotozoal Agents - administration & dosage ; Antiprotozoal Agents - adverse effects ; Drug Overdose ; Humans ; Infant, Newborn ; Medication Errors - adverse effects ; Prognosis ; Pyrimethamine - administration & dosage ; Pyrimethamine - adverse effects ; Seizures - chemically induced ; Toxoplasmosis, Congenital - drug therapy</subject><ispartof>Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2011-10, Vol.18 (10), p.1084-1086</ispartof><rights>Copyright © 2011 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21885264$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Genuini, M</creatorcontrib><creatorcontrib>Freihuber, C</creatorcontrib><creatorcontrib>Girard, I</creatorcontrib><creatorcontrib>de Montgolfier, I</creatorcontrib><creatorcontrib>Kieffer, F</creatorcontrib><creatorcontrib>Mitanchez, D</creatorcontrib><title>Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation?</title><title>Archives de pédiatrie : organe officiel de la Société française de pédiatrie</title><addtitle>Arch Pediatr</addtitle><description>Curative treatment of congenital toxoplasmosis is based on the association of pyrimethamine and sulfonamide. There is currently no pediatric galenic formulation. We report the case of a newborn child affected by asymptomatic congenital toxoplasmosis who received an overdose of pyrimethamine. The patient received a dose of pyrimethamine 4 times, equal to 100 times the recommended dose, due to an error in the prescription. He had partial seizures 48 h after the last medicinal absorption. We noted a lack of appetite and vomiting, with a favorable progression in 5 days. Blood analysis showed isolated, spontaneously regressive moderate cholestasis. We propose a pharmacological clarification on the treatment of congenital toxoplasmosis.</description><subject>Antiprotozoal Agents - administration & dosage</subject><subject>Antiprotozoal Agents - adverse effects</subject><subject>Drug Overdose</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Medication Errors - adverse effects</subject><subject>Prognosis</subject><subject>Pyrimethamine - administration & dosage</subject><subject>Pyrimethamine - adverse effects</subject><subject>Seizures - chemically induced</subject><subject>Toxoplasmosis, Congenital - drug therapy</subject><issn>1769-664X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kM1KxDAYRYMgzjj6BiLZuWr98tM240Zk8A8G3cxCcFG-tgmTsW1qkqLz9hYdV3dzOJd7CblgkDJg-fUuRV8Pukk5MJZCkQIXR2TOinyZ5Ll8m5HTEHYAoECJEzLjTKmM53JO3l-06zFiS20f3betMVrX0y8bt3TYe9vpuMXO9vqGehs-aDNqGh2NW02xCrqvNXWGTtUWo7c1Nc53Y_sruT0jxwbboM8PuSCbh_vN6ilZvz4-r-7WyZBlMik45FIwWTPJpBEGTKNAswazqmFcCKUYFohCoRRVYXjGl7XhBUIGBccMxYJc_WkH7z5HHWLZ2VDrtsVeuzGUaplzkJN8Ii8P5Fh1uimHaR_6ffl_h_gBZ49iSg</recordid><startdate>201110</startdate><enddate>201110</enddate><creator>Genuini, M</creator><creator>Freihuber, C</creator><creator>Girard, I</creator><creator>de Montgolfier, I</creator><creator>Kieffer, F</creator><creator>Mitanchez, D</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201110</creationdate><title>Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation?</title><author>Genuini, M ; Freihuber, C ; Girard, I ; de Montgolfier, I ; Kieffer, F ; Mitanchez, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p554-72064314c1414f3f0fd80e1da5bd1233881a7aa38a43b7f2529cf27a05072a5a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2011</creationdate><topic>Antiprotozoal Agents - administration & dosage</topic><topic>Antiprotozoal Agents - adverse effects</topic><topic>Drug Overdose</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Medication Errors - adverse effects</topic><topic>Prognosis</topic><topic>Pyrimethamine - administration & dosage</topic><topic>Pyrimethamine - adverse effects</topic><topic>Seizures - chemically induced</topic><topic>Toxoplasmosis, Congenital - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Genuini, M</creatorcontrib><creatorcontrib>Freihuber, C</creatorcontrib><creatorcontrib>Girard, I</creatorcontrib><creatorcontrib>de Montgolfier, I</creatorcontrib><creatorcontrib>Kieffer, F</creatorcontrib><creatorcontrib>Mitanchez, D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Archives de pédiatrie : organe officiel de la Société française de pédiatrie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Genuini, M</au><au>Freihuber, C</au><au>Girard, I</au><au>de Montgolfier, I</au><au>Kieffer, F</au><au>Mitanchez, D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation?</atitle><jtitle>Archives de pédiatrie : organe officiel de la Société française de pédiatrie</jtitle><addtitle>Arch Pediatr</addtitle><date>2011-10</date><risdate>2011</risdate><volume>18</volume><issue>10</issue><spage>1084</spage><epage>1086</epage><pages>1084-1086</pages><eissn>1769-664X</eissn><abstract>Curative treatment of congenital toxoplasmosis is based on the association of pyrimethamine and sulfonamide. There is currently no pediatric galenic formulation. We report the case of a newborn child affected by asymptomatic congenital toxoplasmosis who received an overdose of pyrimethamine. The patient received a dose of pyrimethamine 4 times, equal to 100 times the recommended dose, due to an error in the prescription. He had partial seizures 48 h after the last medicinal absorption. We noted a lack of appetite and vomiting, with a favorable progression in 5 days. Blood analysis showed isolated, spontaneously regressive moderate cholestasis. We propose a pharmacological clarification on the treatment of congenital toxoplasmosis.</abstract><cop>France</cop><pmid>21885264</pmid><doi>10.1016/j.arcped.2011.07.023</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1769-664X |
| ispartof | Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2011-10, Vol.18 (10), p.1084-1086 |
| issn | 1769-664X |
| language | fre |
| recordid | cdi_proquest_miscellaneous_896204414 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Antiprotozoal Agents - administration & dosage Antiprotozoal Agents - adverse effects Drug Overdose Humans Infant, Newborn Medication Errors - adverse effects Prognosis Pyrimethamine - administration & dosage Pyrimethamine - adverse effects Seizures - chemically induced Toxoplasmosis, Congenital - drug therapy |
| title | Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T07%3A00%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neonatal%20intoxication%20with%20pyrimethamine:%20risk%20due%20to%20the%20absence%20of%20pediatric%20formulation?&rft.jtitle=Archives%20de%20p%C3%A9diatrie%20:%20organe%20officiel%20de%20la%20Soci%C3%A9t%C3%A9%20fran%C3%A7aise%20de%20p%C3%A9diatrie&rft.au=Genuini,%20M&rft.date=2011-10&rft.volume=18&rft.issue=10&rft.spage=1084&rft.epage=1086&rft.pages=1084-1086&rft.eissn=1769-664X&rft_id=info:doi/10.1016/j.arcped.2011.07.023&rft_dat=%3Cproquest_pubme%3E896204414%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=896204414&rft_id=info:pmid/21885264&rfr_iscdi=true |